Insight Molecular Diagnostics, Inc. (IMDX)
2.49
+0.03
(+1.22%)
USD |
NASDAQ |
Nov 06, 16:00
2.50
+0.01
(+0.40%)
After-Hours: 20:00
Insight Molecular Diagnostics Profit Margin (Quarterly) : -4.71K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.71K% |
| March 31, 2026 | -13.41K% |
| December 31, 2025 | -2.02K% |
| September 30, 2025 | -4.17K% |
| June 30, 2025 | -1.88K% |
| March 31, 2025 | -312.0% |
| December 31, 2024 | -2.26K% |
| September 30, 2024 | -11.73K% |
| June 30, 2024 | -4.36K% |
| March 31, 2024 | -5.19K% |
| December 31, 2023 | -5.09K% |
| September 30, 2023 | -1.51K% |
| June 30, 2023 | -1.80K% |
| Date | Value |
|---|---|
| March 31, 2023 | |
| September 30, 2022 | -2.71K% |
| June 30, 2022 | -575.5% |
| March 31, 2022 | -898.2% |
| December 31, 2021 | -999.9% |
| September 30, 2021 | -1.40K% |
| June 30, 2021 | -516.9% |
| March 31, 2021 | -348.7% |
| December 31, 2020 | -1.25K% |
| September 30, 2020 | -1.22K% |
| June 30, 2020 | -6.37K% |
| March 31, 2020 | -48.32K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -33.31K% |
| Agenus, Inc. | 4.98% |
| Amgen, Inc. | 37.29% |
| Anika Therapeutics, Inc. | -1.02% |
| BioCryst Pharmaceuticals, Inc. | 21.03% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -129.8% |
| Gross Profit Margin (Quarterly) | -202.5% |
| Operating Margin (Quarterly) | -3.80K% |
| Return on Net Operating Assets | -337.7% |